Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Salk Institute Awarded Historic $42 Million Grant to Establish Center for Genomic Medicine

Published: Thursday, January 24, 2013
Last Updated: Thursday, January 24, 2013
Bookmark and Share
World-renowned research facility receives largest single donation in its 53-year history.

The Salk Institute for Biological Studies has received a $42 million gift-the largest in the Institute's history-to establish the Helmsley Center for Genomic Medicine (HCGM), a research center dedicated to decoding the common genetic factors underlying many complex chronic human diseases.

The award, from the Leona M. and Harry B. Helmsley Charitable Trust, will support interdisciplinary research that paves the way to new therapies for chronic illnesses such as cancer, diabetes and Alzheimer's disease.

"This remarkable gift reflects the strong partnership between Salk and the Helmsley Charitable Trust and their commitment that the Institute stay at the forefront of biomedical research," said William R. Brody, Salk president. "By working together, Salk and the Trust have successfully sculpted this unprecedented grant. It will provide vital funding to enable our scientists to pursue the kinds of transformative scientific discoveries and advancements that will have worldwide impact on people's health for generations to come. With its scale and unique focus on supporting vitally important basic scientific research, the Helmsley Charitable Trust stands among philanthropy's vanguard in promoting innovative cross-disciplinary initiatives such as this one."

John Codey, a trustee for the Helmsley Charitable Trust, said that the Trust decided to establish the center at Salk because of the Institute's long track record of ground-breaking discoveries and the growing need to address chronic diseases.

"Millions of people suffer from chronic illnesses, and these diseases are placing an unsustainable burden on our healthcare system," Codey says. "The Helmsley Center for Genomic Medicine will help to address this by serving as an incubator for tomorrow's clinical treatments and cures."

Broadly defined, genomic medicine is the science of using maps of human DNA-the genome-to understand how cells operate and generate new therapies for human disease. The Helmsley Center for Genomic Medicine (HCGM)will allow Salk researchers to use genomic data and powerful new technologies to decipher the molecular and genetic mechanisms that go awry in chronic disease.

The center will include scientists who are leaders in a range of biomedical research fields, including stem cell biology, endocrinology, cancer biology, metabolism,neurobiology, developmental biology, inflammation, and gene therapy. They will combine their efforts to understand how certain cellular pathways serve as lynchpins for chronic diseases, such as cancer,diabetes and neurodegenerative disorders. For instance, Salk researchers are finding that the cellular pathways involved in inflammation play a role in a range of diseases, including diabetes, heart disease and cancer. This suggests that developing therapies that address inflammation could help prevent and treat a broad range of disorders.

The all-star team of Salk scientists includes Inder Verma, Fred H. Gage, Ronald Evans, Juan Carlos Izpisua Belmonte, Reuben Shaw and Marc Montminy.

"The scientific collaborations fostered by HCGM will far exceed the efforts of any individual participating laboratory," says Salk scientist Inder Verma, project leader of the new partnership between Salk and the Helmsley Charitable Trust. "The state-of-the-art core facilities made possible by this grant will offer access to technology and support that no researcher could get on their own."

In addition to charting the common genomic basis for chronic conditions and uncovering new potential targets for therapies, the center's researchers will explore how genomic networks control stem cell development. This will allow researchers to manipulate genes to make stem cells useful for studying disease and regenerative medicine. The center will also explore how disease alters the epigenome, chemical switches on the DNA molecule which influences genetic activity, which may explain why patients with similar genetic profiles respond differently to treatment.

"Chronic illness leads to distinctive changes at the genetic level and this gives us a new way to approach diagnosis and treatment," says Ronald M. Evans, professor in Salk's Gene Expression Laboratory. "HCGM will allow experts in cellular genetics and genomics to team up and seek out common molecular signatures of disease. Chronic diseases are complex, and to understand them you need to blend science, medicine and new advances in drug discovery by approaching them from different angles."

The Helmsley Charitable Trust's important gift is one of several major contributions made to Salk by the Trust. In 2009, the Trust issued a $5.5 million grant to found the Salk Center for Nutritional Genomics to study nutrition at the molecular level and its impact on the role of metabolism in diabetes, obesity, cancer, exercise physiology and lifespan. The Trust awarded an additional $15 million in 2010 to create a collaborative stem cell project involving Salk and Columbia University to fast-track the use of induced pluripotent stem cells to gain new insight into disease mechanisms and screen for novel therapeutic drugs.

"Our philanthropic investment in Salk has produced tangible and impactful results, upon which this latest grant will build significantly," says Codey. "With the Helmsley Center for Genomic Medicine we are partnering with Salk to tackle some of the most devastating diseases facing humankind."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Not All Organs Age Alike
Study shows first comprehensive view of how proteins age in different organs.
Monday, September 21, 2015
Epigenetic Variations Between Tissues
A Salk Institute-led team has generated a map of the human methylome, gaining insight into patterns of DNA methylation of various tissues.
Wednesday, June 03, 2015
New Stem Cell May Overcome Hurdles for Regenerative Medicine
Scientists have discovered a novel type of pluripotent stem cell capable of developing into any type of tissue whose identity is tied to their location in a developing embryo.
Monday, May 11, 2015
Vital Step in Stem Cell Growth Revealed
Salk scientists' finding could aid regenerative and cancer therapies.
Thursday, May 07, 2015
Gene-Editing Technique Offers Hope For Hereditary Diseases
Salk scientists use molecular "scissors" to eliminate mitochondrial mutations in eggs and embryos.
Monday, April 27, 2015
Cellular Scissors Chop up HIV Virus
Salk scientists re-engineered the bacterial defense system CRISPR to recognize HIV inside human cells and destroy the virus, offering a potential new therapy.
Thursday, March 12, 2015
Powerful Method To Speed Cancer Drug Discovery Unveiled
The new method lets researchers identify weak and previously undetectable interactions between proteins inside living cells.
Monday, November 24, 2014
Salk Scientists Discover a Key to Mending Broken Hearts
Researchers regenerate and heal mouse hearts by using the molecular machinery the animals had all along.
Wednesday, November 12, 2014
Turning Human Skin Cells Into Immune-Fighting White Blood Cells
The fast and safe technique developed at the Salk Institute circumvents problems that have hindered regenerative medicine.
Friday, September 12, 2014
No Extra Mutations in Modified Stem Cells, Study Finds
New results ease previous concerns that gene-editing techniques-used to develop therapies for genetic diseases-could add unwanted mutations to stem cells.
Saturday, July 12, 2014
Salk Institute Receives $3M Gift for Ageing Research
The gift from the Glenn Foundation for Medical Research will allow the Institute to continue conducting research to understand the biology of normal human aging and age-related diseases.
Friday, May 23, 2014
Circadian Clock Gene Linked to Eating Schedule
Research from the Salk Institute has shown that mutations in the circadian genes could drive night eating syndrome.
Friday, May 23, 2014
New Stem Cell Research Points to Early Indicators of Schizophrenia
Salk scientists show fundamental differences in early neurons from patients with schizophrenia, supporting the theory that risk for the disease may begin in the womb.
Wednesday, May 14, 2014
Salk Institute and Stanford Lead New $40M Stem Cell Genomics Center
Collaborative research center will bridge genomics and stem cell projects to find new therapies.
Sunday, February 02, 2014
Salk Scientists Discover more Versatile Approach to Creating Stem Cells
New method should hasten promise of regenerative medicine.
Wednesday, July 24, 2013
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!